000 | 01930 a2200565 4500 | ||
---|---|---|---|
005 | 20250517061957.0 | ||
264 | 0 | _c20160711 | |
008 | 201607s 0 0 eng d | ||
022 | _a1745-6215 | ||
024 | 7 |
_a10.1186/s13063-015-0990-9 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSun, Xiao | |
245 | 0 | 0 |
_aThe cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: a randomized, double-blind, placebo-controlled, multicenter design. _h[electronic resource] |
260 |
_bTrials _cNov 2015 |
||
300 |
_a496 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 |
_aBlood Glucose _xdrug effects |
650 | 0 | 4 |
_aChina _xepidemiology |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 | _aCost-Benefit Analysis |
650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xblood |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aDrug Costs |
650 | 0 | 4 |
_aDrugs, Chinese Herbal _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHealth Knowledge, Attitudes, Practice |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypoglycemic Agents _xadministration & dosage |
650 | 0 | 4 | _aIncidence |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPatient Education as Topic _xeconomics |
650 | 0 | 4 |
_aPrediabetic State _xblood |
650 | 0 | 4 | _aRisk Reduction Behavior |
650 | 0 | 4 | _aTablets |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aGuo, Liping | |
700 | 1 | _aShang, Hongcai | |
700 | 1 | _aRen, Ming | |
700 | 1 | _aWang, Yue | |
700 | 1 | _aHuo, Da | |
700 | 1 | _aLei, Xiang | |
700 | 1 | _aWang, Hui | |
700 | 1 | _aZhai, Jingbo | |
773 | 0 |
_tTrials _gvol. 16 _gp. 496 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1186/s13063-015-0990-9 _zAvailable from publisher's website |
999 |
_c25415741 _d25415741 |